Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 17/20 | 0.55 |
| ▸ | HDAC4 | P56524 | 16/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 17/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14917946 | 0.83 | HDAC6 (0.55) | HDAC6HDAC4HDAC1HDAC5HDAC8 | |
| SCHEMBL14917797 | 0.82 | HDAC6 (0.71) | HDAC6HDAC4HDAC1HDAC5HDAC8 | |
| SCHEMBL29877691 | 0.82 | HDAC6 (0.71) | HDAC6HDAC4HDAC1HDAC5HDAC8 | |
| SCHEMBL23711190 | 0.80 | HDAC6 (0.65) | HDAC6HDAC4HDAC1HDAC5HDAC8 | |
| SCHEMBL22574764 | 0.79 | HDAC4 (0.52) | HDAC6HDAC4HDAC1HDAC5HDAC8 | |
| SCHEMBL16104090 | 0.79 | HDAC6 (0.59) | HDAC6HDAC4HDAC1HDAC5HDAC8 | |
| SCHEMBL18824381 | 0.77 | HDAC4 (0.66) | HDAC6HDAC4HDAC1HDAC8 | |
| SCHEMBL28503078 | 0.77 | HDAC4 (0.49) | HDAC6HDAC4HDAC1HDAC8 | |
| SCHEMBL14993379 | 0.77 | HDAC6 (0.56) | HDAC6HDAC4HDAC1HDAC5HDAC8 | |
| SCHEMBL22574705 | 0.76 | HDAC4 (0.52) | HDAC6HDAC4HDAC1HDAC5HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022129188-A1 | 1,2,4-OXADIAZOL-3-YL PYRIMIDINES AS FUNGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2022-06-23 | — | — | WO | disclosed |
| WO-2013066831-A1 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2013-05-10 | — | — | WO | disclosed |
| WO-2013066839-A2 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2013-05-10 | — | — | WO | disclosed |
| WO-2013066831-A1 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2013-05-10 | — | — | WO | disclosed |
| WO-2013066839-A2 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2013-05-10 | — | — | WO | disclosed |